CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 48 enrolled
Drug / intervention
Calypso Beacon Implantationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02111681
NCT02111681N/ACompleted

Calypso-based Deep Inspiration Breath Hold (DIBH) Radiation Treatments of Lung Cancer

Memorial Sloan Kettering Cancer Center·interventional·Posted Apr 11, 2014·Updated Sep 26, 2025

In Brief

A clinical study evaluating Calypso Beacon Implantation for Non-small Cell Lung Cancer (NSCLC). Completed, enrolled 48 participants across 4 sites.

Detailed Summary

The purpose of this study is to test the use of Calypso beacon implants as a way to determine where the lung tumor is located during radiation treatment. The Calypso beacons are small devices that are implanted in the lungs, near the tumor. They are able to send a signal to a tracking system to show where they are, and where the tumor is, as the patient holds their breath for the radiation treatment. The investigators want to find out what effects, good and/or bad, that this has on the patient and the way they treat the cancer in your lungs.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedApr 11, 2014
Enrollment StartApr 1, 2014
Primary CompletionJul 1, 2024
TodayJul 2, 2026
Enrollment to primary: 10.3 yearsPosted 12.2 years ago

Interventions

Calypso Beacon Implantationdevice

Bronchoscopic Calypso Beacon Implantation